Challenging pharmaceutical industry political power in Maine and Vermont.
A comparison of the Vermont and Maine cases of attempting to control pharmaceutical prices in the year 2000 shows that the Maine legislators were more successful in challenging pharmaceutical industry political power. This comparison shows that challenging the industry was aided by (1) mobilizing public support through grassroots organizations, (2) including independent pharmacists in negotiations over the legislation, and (3) developing state purchasing power leverage.
Castellblanch
Ramón
R
Health Education Department, San Francisco State University, California, USA.
D000368:Aged; D003363:Cost Control / Q000331:legislation & jurisprudence; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D008281:Maine; D008484:Medicaid / Q000191:economics / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence*; D017008:Negotiating; D010595:Pharmacists; D011057:Politics; D011209:Power, Psychological; D013221:State Health Plans / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States; D014707:Vermont